StockData
Definium Therapeutics, Inc. logo

Definium Therapeutics, Inc. (DFTX) stock

DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$29.38−0.78 (-2.59%)

Close on Nov 17, 2026Market cap $3.95BP/E –Yield –

Definium Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Definium Therapeutics's market cap was $4.63B on Nov 11, 2026, against $971.19M a year earlier. Over the last 5 years it ranged from $82.59M to $5.34B, with a median of $454.07M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.63B+350.5%
2025Dec 31, 2025$1.03B+81.0%
2024Dec 31, 2024$567.87M+287.0%
2023Dec 29, 2023$146.75M+77.7%
2022Dec 30, 2022$82.59M-77.5%
2021Dec 31, 2021$367.37M–

More Definium Therapeutics figures

See a number that looks wrong?